Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

导出原文传递

翻译打印收藏纠错

作者： Schoretsanitis, Georgios ^[1] ; Meyer, Jonathan M. ^[2] ; Conca, Andreas ^[3] ; Hiemke, Christoph ^[4]

作者单位： Northwell Health,Zucker Hillside Hosp ^[1] Sch Med,Univ Calif San Diego ^[2] Dipartimento Psichiatria,Comprensorio Sanitario Bolzano ^[3] Dept Psychiat & Psychotherapy,Univ Med Ctr Mainz ^[4]

关键词 Adherence second-generation antipsychotics depot long-acting injectable pharmacokinetics schizophrenia Therapeutic drug monitoring (TDM)transition PALMITATE 3-MONTH FORMULATION D-2 RECEPTOR OCCUPANCY PALIPERIDONE PALMITATE OPEN-LABEL POPULATION PHARMACOKINETICS SERUM CONCENTRATIONS PLASMA-CONCENTRATION RELAPSE PREVENTION CLINICAL-RESPONSE META-REGRESSION

发布时间 2023-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on drug metabolism & toxicology

2023年19卷1/6期

189-202页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

Expert opinion on drug metabolism & toxicology

相似文献

Expert opinion on drug metabolism & toxicology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

Expert opinion on drug metabolism & toxicology

相似文献

Expert opinion on drug metabolism & toxicology

相关期刊

检索历史清除